# Grand Pharma subsidiary to acquire Nanjing Kainite Medical Technology

Grand Pharma's subsidiary agreed to acquire Nanjing Kainite Medical Technology through a series of capital subscriptions and share purchases totaling CNY 29.4 million, with an additional CNY 100 million capital injection into a fund, to build a pan-interventional diagnosis and treatment platform.

- Type: Acquisition
- Announced: 2020-07-27
- Where: Nanjing, China
- Value: $4.20M (29.4M CNY)
- Status: announced
- Products: interventional medical devices, stroke treatment products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Grand Pharmaceutical Group](https://endata.com/companies/28076.md)
- [Nanjing Kainite Medical Technology](https://endata.com/companies/48876.md) (target)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/321631.html), 2020-07-27: "待完成股本认购事项及收购事项后，远大医药将会持有目标公司的100%股本权益。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.